Seasonic’s New High Efficiency 1.6 kW Platform for Broad Power Supply Portfolio Use Built With Transphorm GaN
Transphorm Inc.— the leader in the design and manufacturing of the highest reliability and first JEDEC- and AEC-Q101 qualified gallium nitride (GaN) semiconductors—today announced that Seasonic Electronics Co. uses Transphorm’s high voltage (HV) GaN FETs in its new 1600 Watt (W) bridgeless totem-pole power factor correction (PFC) platform: the 1600T. The 1600T is the power supply manufacturer’s highest performing PFC platform to date at greater than 99 percent efficiency. Notably, the introduction of GaN delivers a two percent efficiency increase and 20 percent power density increase over Seasonic’s previous Silicon-based platform.
The 1600T platform will be scaled and deployed in various catalog products targeting the Charger (e-scooters, industrial, etc.), Gaming, Server, and PC power markets.
“When researching semiconductor technologies that would enable us to reach world-leading efficiency levels, gallium nitride stood out as an attractive alternative to Silicon,” said Paul Lin, Director of Research and Development, Seasonic. “We knew the bridgeless totem-pole PFC was the topology we would use in our first high voltage GaN power platform. So, we needed power semiconductors capable of successfully capitalizing on that topology. What’s more, we wanted a GaN solution that could be backed by our standard warranty. We ultimately opted for Transphorm’s FETs within the 1600T given their proven performance and reliability that allowed us to meet those requirements.”
Designing with Confidence: Transphorm Q+R
The 1600T platform employs Transphorm’s TP65H035WS device, a 650 V GaN FET with an RDS(on) of 35 mΩ in a standard TO-247 package. The transistor achieves increased efficiency in hard-and soft-switched circuits, providing power systems engineers options when designing products. Further, the TP65H035WS pairs with commonly-used gate drivers to simplify designs while controlling costs.
Transphorm prioritizes quality and reliability (Q+R) when developing its GaN platforms and FETs. An outcrop of that prioritization is increased safety for designers; Transphorm GaN typically delivers greater headroom and noise immunity when compared to other available GaN FETs. The TP65H035WS’ typical gate threshold is 4 V with a maximum gate voltage of ±20 V.
Beyond the technology itself, Transphorm offers in-depth field application support and hands on training given GaN’s relative newness in high voltage applications. Seasonic leveraged the semiconductor company’s experts to strengthen the design itself while quickening time to market.
For example, guidance provided helped Seasonic’s team ramp on use of a simple, low-cost digital signal processor (DSP) to control the totem-pole PFC. Transphorm also aided in the platform’s component selection and system layout, ensuring optimal GaN performance. Ultimately, the co-development directly impacted Seasonic’s ability to drive up thermal efficiency while increasing power output—generating a HV GaN platform capable of delivering on Seasonic’s vision.
About Seasonic Electronics
Seasonic is a truly global company. Headquartered in Taipei, Taiwan, we export our products from our factory in China to our offices in the USA, Europe, Japan, as well as to other parts of the world. As a leader in innovation, our company’s main focus is to bring the latest technology at the best possible value to all our customers, who require cutting-edge features combined with market leading performance and total reliability. The strong competition in the IT industry gives us constant challenges, which strengthen our resolve to become and stay the best. Today, the Seasonic name is the equivalent of high performance, excellence and reliability. Our design and engineering team is passionate about creating new solutions that reply to the needs of our customers and connect to the latest market trends.
Transphorm (transphormusa.com) designs, manufactures, and sells the highest performance, highest reliability GaN semiconductors for high-voltage power conversion applications. Holding one of the largest Power GaN IP portfolios (1000+ issued and pending patents worldwide), Transphorm produces the industry’s only JEDEC and AEC-Q101 qualified GaN FETs. This is due to a vertically-integrated business approach, which allows for innovation at every stage: materials and device design and manufacture, fabrication, packaging, reference circuit designs, and application support.
Heather Ailara, 845-424-6341
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Tilaa tiedotteet sähköpostiisi
Haluatko tietää asioista jo ennen kuin ne uutisoidaan? Kun tilaat tiedotteemme, saat ne sähköpostiisi yhtä aikaa suomalaisen median kanssa. Tilauksen voit halutessasi perua milloin tahansa.
Lue lisää julkaisijalta Business Wire
Pierre Fabre & Array BioPharma Announce a 62% Observed OS at One Year from the Phase 3 BEACON CRC Safety Lead-In of the Combination of Encorafenib, Binimetinib and Cetuximab in BRAF-Mutant CRC at the ESMO GI Congress23.6.2018 14:00 | Tiedote
Not intended for UK- and US-based media Pierre Fabre and its partner Array BioPharma Inc. today announced updated safety and efficacy results, including OS, from the safety lead-in of the Phase 3 BEACON CRC trial evaluating the triplet combination of encorafenib, a BRAF inhibitor, binimetinib, a MEK inhibitor and cetuximab, an anti-EGFR antibody, in patients with BRAF V600E -mutant metastatic colorectal cancer (CRC). The results showed that, at the time of analysis, the OS data were fully mature through 12.6 months and that the median OS had not yet been reached. The one-year overall survival rate for this cohort was 62%. These data were presented in an oral presentation on Saturday, June 23, at the ESMO 20th World Congress on Gastrointestinal Cancer in Barcelona, Spain. The median progression-free survival (mPFS) for patients treated with the triplet was 8 months [95% CI 5.6-9.3] and is similar between patients receiving one prior line of therapy and patients receiving two prior lines
Compelling Data for LONSURF® (trifluridine/tipiracil) in Metastatic Colorectal Cancer Presented at ESMO’s World Congress on Gastrointestinal Cancer by Servier and Taiho23.6.2018 11:10 | Tiedote
Servier and Taiho Pharmaceutical Co., Ltd. today announced that the TASCO-1 trial demonstrated promising results for LONSURF® (trifluridine/tipiracil) in combination with bevacizumab in patients with previously untreated metastatic colorectal cancer (mCRC) who are not suitable for intensive treatment, with a median progression-free survival (PFS) of 9.2 months (ranging from 7.6 to 11.5 months). A second non-comparative arm in the trial, evaluated the outcome of patients treated with the current standard of care of capecitabine in combination with bevacizumab. The median PFS of this arm was 7.8 months (ranging from 5.5 to 10.1 months). “Colorectal cancer is the third most common cancer in the world. While there has been some progress in treatment, there are still few options for patients with metastatic disease who are not suitable for intensive treatment,” said Professor Eric Van Cutsem, Head of Digestive Oncology at the University of Leuven, Belgium. “These compelling results suggest
Softomotive and Accelerate RPA Partner to Help Enterprises Achieve Faster Time to Value from RPA22.6.2018 18:13 | Tiedote
Softomotive, a world–class Robotic Process Automation (RPA) technology provider offering best time to value and affordability for all sizes and types of enterprises, is pleased to announce a strategic partnership with AccelerateRPA, a high calibre professional services provider of trained and certified RPA Consultants within Robotic Process Automation. This partnership means that customers and end users of Softomotive’s software, will have additional knowledgeable and professional guidance available to help achieve significant value quickly from their investment in RPA. Companies who are looking to implement Softomotive’s RPA product suite (WinAutomation and ProcessRobot software) will now have direct access to AccelerateRPA’s highly skilled consultants and Developers. Further, AccelerateRPA has also become a licensed reseller of Softomotive’s products, offering customers a single point of contact for delivering both RPA software and services. Ashley Hudson, Director of AccelerateRPA,
Ascend Performance Materials Announces Price Increase for Intermediate Materials22.6.2018 17:00 | Tiedote
Ascend Performance Materials announced today a price increase for its intermediate materials. The price increase will take effect globally on July 1, 2018, and includes the following terms: Material Price Increase Terms Hexamethylene diamine (HMD) $0.17/lb. • As contracts allow. • Non-contract business – price determined on an order-by-order basis. Acrylonitrile (AN) $0.20/lb. • As contracts allow. • Non-contract business – price determined on an order-by-order basis. Customers should contact their local sales representative for additional information. About Ascend Performance Materials Ascend Performance Materials is a global premium provider of high-quality plastics, fibers and chemicals and is the world’s largest integrated producer of PA66 resin. Headquartered in Houston, Texas, Ascend has eight global locations, including five fully-integrated manufacturing facilities located in the southeastern United States, all dedicated to the innovation and safe production of nylon 6,6. With
Different Countries, Different Customs: Get Ready for the Motorbike Holidays with Moto-tyres.co.uk22.6.2018 16:41 | Tiedote
Pack your bags, close the boot and get away on holiday? When you start your holidays on a motorcycle, you usually have to consider a few things more when getting ready for your trip. The right preparation is therefore a must. So that nothing stands in the way of a smooth journey, Moto-tyres.co.uk has put together some tips for your next trip. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180622005345/en/ Different countries, different customs: get ready for the motorbike holidays with Moto-tyres.co.uk (Photo: Business Wire) Whether a weekend trip or extended adventure, it all depends on the right equipment. Functional clothing, protectors and rain protection are a must on long trips. Wearing a suitable motorcycle helmet is a legal requirement almost everywhere. However, there are also very different rules and regulations for motorbike equipment and accessories depending on the destination, and you should familiarise yoursel
Boehringer Ingelheim bolsters biologics research and development with 230 million euro investment in new development center22.6.2018 15:00 | Tiedote
Today Boehringer Ingelheim announced a 230 million euro investment into a new Biologicals Development Center (BDC) at the company’s Research and Development site in Biberach, Germany during the foundation stone laying for the new center. “The BDC is another key building block supporting the company’s long-term strategy for increasing the pipeline’s share of biologicals. This is particularly driven by two of our core areas, immune oncology and immunology,” says Dr. Fridtjof Traulsen, Corporate Senior Vice President Development at Boehringer Ingelheim. “The share of new biological entities in Boehringer Ingelheim’s research pipeline has been consistently increasing over the past few years and has now reached forty percent.” The BDC will help to maximize synergies by integrating biologicals analytical and process development as well as manufacturing for clinical studies into one seamless unit, while at the same time increasing development capacity. Following a staggered launch beginning i
Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.Tutustu uutishuoneeseemme